For those of you who have tried or are on PARP inhibitors, which one did you use and at what point did you use them? Was it before chemo or after chemo? Did insurance cover the cost?
Looking at the NCCN guidelines, which my husband's MO refers to often, they suggest Olaparib (Lynparrza) before chemo and Rucaparib (Rubraca) after chemo. They also list two other newer drugs. I'm looking at page 53 in these guidelines - nccn.org/patients/guideline...
Zytiga is starting to fail my husband so he will be getting another PSMA scan in a few weeks and looking at what's next. He does have a somatic BRCA2 genetic defect.
I went down a rabbit hole on this topic after reading this news article about a study on Rucaparib's metabolite M324 and the possible use in Parkinson's. My husband also has Parkinson's.
From the article, Specifically, the synergy demonstrated between Rucaparib and M324 in prostate cancer cell lines could have an impact on clinical trials for advanced stages of this type of cancer. On the other hand, the fact that M324 is capable of reducing the abnormal accumulation of α-synuclein in neurons derived from stem cells of a Parkinson's patient highlights the therapeutic potential of this metabolite and its possible pharmacological application for the treatment of this neurodegenerative disease. - msn.com/en-us/health/other/...
The folks who contributed to this study have a commercial interest in a range of drug targets, including PARPs. Maybe they are being overly optimistic of the possibilities, but I do find it interesting.